---
title: The nomination committee's recommendation to the general meeting of Gentian Diagnostics ASA
description: The nomination committee's recommendation to the general meeting of Gentian Diagnostics ASA
---

Moss, 9 May 2022

 

The nomination committee of Gentian Diagnostics ASA has submitted its recommendation regarding the election of members to the Company's board of directors and the nomination committee, including proposed remuneration to members of the board and nomination committee.

The recommendation is [enclosed](https://www.gentian.com/hubfs/IR%20documents/Nomination%20committee%20recommendation.pdf) and available on [www.gentian.com](https://www.gentian.com)

This information is subject to the disclosure requirements pursuant to Section 5-12 of the Norwegian Securities Trading Act.

[Nomination committee recommendation](https://www.gentian.com/hubfs/IR%20documents/Nomination%20committee%20recommendation.pdf)

IR contact:

Njaal Kind, CFO and COO  
[njaal.kind@gentian.no](mailto:njaal.kind@gentian.no)  
+47 919 06 525 (mobile)

 

To see the announcement follow this link: [https://newsweb.oslobors.no/message/561518](https://newsweb.oslobors.no/message/561518)

 

This is an automatic notification about an announcement from Gentian Diagnostics ASA.

### You may also read

[Jul 02, 2026 - Ole Sørlie](https://www.gentian.com/investor-relations-stock-information/investors-news/the-nomination-committees-recommendation-to-the-general-meeting-of-gentian-diagnostics-asa#)

##### [Gentian Diagnostics: Invitation to presentation of second quarter results](https://www.gentian.com/investor-relations-stock-information/investors-news/gentian-diagnostics-invitation-to-presentation-of-second-quarter-results-1)

Gentian Diagnostics ASA will present its second quarter 2026 results on 9 July 2026 at 09.00 CEST. The..

[Read more](https://www.gentian.com/investor-relations-stock-information/investors-news/gentian-diagnostics-invitation-to-presentation-of-second-quarter-results-1)

[Jun 24, 2026 - Ole Sørlie](https://www.gentian.com/investor-relations-stock-information/investors-news/the-nomination-committees-recommendation-to-the-general-meeting-of-gentian-diagnostics-asa#)

##### [ESSANGE REAGENTS AND GENTIAN DIAGNOSTICS ANNOUNCE COLLABORATION AGREEMENT](https://www.gentian.com/investor-relations-stock-information/investors-news/essange-reagents-and-gentian-diagnostics-announce-collaboration-agreement)

Amsterdam / Moss, 24 June 2026 ESSANGE REAGENTS AND GENTIAN DIAGNOSTICS ANNOUNCE COLLABORATION AGREEMENT..

[Read more](https://www.gentian.com/investor-relations-stock-information/investors-news/essange-reagents-and-gentian-diagnostics-announce-collaboration-agreement)

[May 29, 2026 - Ole Sørlie](https://www.gentian.com/investor-relations-stock-information/investors-news/the-nomination-committees-recommendation-to-the-general-meeting-of-gentian-diagnostics-asa#)

##### [Mandatory notification of trade](https://www.gentian.com/investor-relations-stock-information/investors-news/mandatory-notification-of-trade-1780055230560)

Moss, 29 May 2026 Gentian Diagnostics ASA ("Gentian") has today been notified that the following transaction..

[Read more](https://www.gentian.com/investor-relations-stock-information/investors-news/mandatory-notification-of-trade-1780055230560)